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AbstrAct
Objective Digital innovations with internet/mobile phones 
offer a potential cost-saving solution for overburdened 
health systems with high service delivery costs to improve 
efficiency of HIV/STI (sexually transmitted infections) 
control initiatives. However, their overall evidence has 
not yet been appraised. We evaluated the feasibility and 
impact of all digital innovations for all HIV/STIs.
Design Systematic review.
setting/participants All settings/all participants.
Intervention We classified digital innovations into (1) 
mobile health-based (mHealth: SMS (short message 
service)/phone calls), (2) internet-based mobile and/or 
electronic health (mHealth/eHealth: social media, avatar-
guided computer programs, websites, mobile applications, 
streamed soap opera videos) and (3) combined innovations 
(included both SMS/phone calls and internet-based 
mHealth/eHealth).
Primary and secondary outcome measures Feasibility, 
acceptability, impact.
Methods We searched databases MEDLINE via PubMed, 
Embase, Cochrane CENTRAL and Web of Science, 
abstracted data, explored heterogeneity, performed a 
random effects subgroup analysis.
results We reviewed 99 studies, 63 (64%) were from 
America/Europe, 36 (36%) from Africa/Asia; 79% (79/99) 
were clinical trials; 84% (83/99) evaluated impact. Of 
innovations, mHealth based: 70% (69/99); internet based: 
21% (21/99); combined: 9% (9/99). All digital innovations 
were highly accepted (26/31; 84%), and feasible (20/31; 
65%). Regarding impacted measures, mHealth-based 
innovations (SMS) significantly improved antiretroviral 
therapy (ART) adherence (pooled OR=2.15(95%CI: 1.18 to 
3.91)) and clinic attendance rates (pooled OR=1.76(95%CI: 
1.28, 2.42)); internet-based innovations improved clinic 
attendance (6/6), ART adherence (4/4), self-care (1/1), 
while reducing risk (5/5); combined innovations increased 
clinic attendance, ART adherence, partner notifications and 
self-care. Confounding (68%) and selection bias (66%) 
were observed in observational studies and attrition bias in 
31% of clinical trials.
conclusion Digital innovations were acceptable, feasible 
and generated impact. A trend towards the use of internet-
based and combined (internet and mobile) innovations 
was noted. Large scale-up studies of high quality, with 
new integrated impact metrics, and cost-effectiveness are 
needed. Findings will appeal to all stakeholders in the HIV/
STI global initiatives space.
IntrODuctIOn
HIV/STIs remain a public health concern 
worldwide—a million new HIV/STIs are 
acquired every day, with cumulative disease 
burden exceeding 500 million infections.1–5 
Regarding HIV, countries are working hard 
to achieve the new UNAIDS 90-90-90 treat-
ment targets6; however, structural and societal 
barriers, such as stigma, low socioeconomic 
status and geographical isolation, impede 
access to quality care for marginalised popu-
lations who are disproportionately impacted 
by the HIV/AIDS epidemic.7 8 Likewise, a lack 
of timely testing and poor retention in care 
impairs the efforts to control HIV/STIs.7 9 10 
To improve early testing, linkage and reten-
tion in care, healthcare systems globally are 
seeking solutions to improve population 
engagement, awareness and education, and 
efficient care for their hard-to-reach popula-
tions. It is imperative to plug gaps in health-
care service delivery.11 12 Digital innovations 
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Research
strength and limitations of this study
 ► An updated and comprehensive systematic review/
meta-analysis of all innovations in HIV/STI.
 ► Evaluation of study quality with biases, subgroup 
analyses and sensitivity analyses.
 ► Evaluation of metrics and measures for objective 
and subjective data.
 ► Limited data were reported from Sub-Saharan Africa 
and Southeast Asia (29%, 29/99).
 ► Limited evidence (18/99, 18%) was available for 
STIs (other than HIV).
 ► Limited data on cost-effectiveness from high burden 
settings.
 ► A lack of integrated online impact metrics to evaluate 
internet-based eHealth innovations.
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Figure 1 PRISMA (Preferred Reporting Items for Systematic Reviews and Meta-Analyses) flow diagram.
such as electronic health (eHealth), mobile health 
(mHealth) and combined innovations offer promising 
solutions to improve health service delivery. eHealth 
encompasses non-internet and internet-enabled mHealth 
as well as other internet-based health interventions. These 
innovations, together with expanded mobile and internet 
networks, global connectivity and affordability, present 
opportunities to change the future landscape of health-
care service delivery.
The World Bank estimates that globally 96% of the 
world’s population and 70% of the world’s poorest have 
access to a mobile phone.13 Of seven billion, two billion 
(30%) individuals own a smartphone; approximately 
50% of mobile phone users access the internet through 
their phones.14 15 Technological access has created a 
portal for social media and other internet-based health 
interventions.16 A rapid diffusion of mobile phones and 
internet technologies are prime drivers of this disruptive 
phenomenon in health, aptly titled, the creative destruc-
tion of medicine.17 In recent years, visionary foundations 
(Grameen, Bill and Melinda Gates Foundation, UNAIDS, 
Vodafone) have, with funding, created opportunities for 
innovative thinking in health. To date, 95 countries have 
evaluated some digital health innovations.11 This is most 
evident in under-resourced settings where low-cost and 
sustainable solutions are needed to solve complex global 
health challenges.18
Digital innovations were first used in non-communi-
cable diseases and later became popular in infectious 
disease.19 In the field of HIV/STIs, a Lancet study demon-
strated the effectiveness of mHealth-based short message 
service (SMS) innovations on adherence to antiretroviral 
therapy (ART).20 As novel digital innovations and strate-
gies continue to be developed and tested, many smaller 
reviews and systematic reviews were published. However, 
a vast majority of these reviews only evaluated a single 
innovation (eg, SMS, social media), one or two outcomes 
and restricted exploration in select subgroups (people 
living with HIV (PLHIV), pregnant women, adolescents, 
men who have sex with men (MSM)).21–27 These reviews 
failed to provide a comprehensive summary of all inno-
vations for programme planning and research. Due to a 
rapid expansion of digital innovations, and an increased 
popularity of combined innovations (2013), a need for a 
comprehensive up-to-date synthesis on all innovations for 
HIV/STIs was felt.
Our primary objective was to generate a high-quality 
overview/systematic review that summarizes all digital 
innovations across all populations and outcomes in HIV/
STIs. Our secondary objective was to inform researchers, 
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Figure 2 All innovations by outcome type (font size enlarged). ART, antiretroviral therapy; SMS, short message service
policy makers and funders with evidence for their deci-
sions on implementation and scale-up.11 
MethODs
PRISMA (Preferred Reporting Items for Systematic 
Reviews and Meta-Analyses) and Cochrane guidelines 
were followed.28
Data sources and searches
We searched MEDLINE via PubMed, Embase, Cochrane 
CENTRAL and Web of Science for a 21-year period from 
February 1996 up to March 2017, with no language 
restrictions.
search strategy
Keywords used were HIV, AIDS, STI, mhealth, mobile 
health, ehealth, telemedicine, mobile applications and 
social media. For a full search strategy, refer to online 
supplementary appendix file 1. (#1 ('HIV' [MeSH] OR 
'acquired immunodeficiency syndrome' [tiab]), OR 
#2 (sexually transmitted infections [mh] OR sexually 
transmitted disease* [tiab]), AND #3 ('mHealth' [tiab] 
OR 'mobile health' [tiab] OR short messag* [tiab] OR 
'eHealth' [MeSH] OR 'telemedicine' [MeSH] OR social 
medi* [tiab] OR 'mobile applications' [tiab]).
study selection
Two reviewers independently screened and evaluated 
citations for eligibility (JD and RV) and two others (BL 
and SD) independently assessed quality. A senior reviewer 
was consulted (NPP) for discordance.
eligibility criteria
Any clinical trials or observational study designs that 
evaluated any digital (mHealth/eHealth) technology 
with any reported outcomes (refer to figure 1) were 
included.
Data abstraction
Two reviewers (RV, JD) independently abstracted 
all the data. A prepiloted data abstraction form was 
used to abstract the following items: study design, 
study population, sample size, digital innovation 
type, HIV/STIs, outcome measures (eg, impact, 
acceptability and feasibility) and metrics (eg, atten-
dance rate, completion rate, satisfaction) (refer to 
online supplementary appendix file 2). We referred 
to a previously published framework to define and 
further classify the following metrics for impact, 
acceptability and feasibility.29
subgroup pooled analyses
We classified study designs and then classified digital 
innovations into three groups30:
1. mHealth (SMS and phone calls only, that is, non-
internet based);
2. internet-enabled mHealth and other internet-based 
eHealth (mobile application, website, online cam-
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Figure 3 Subgroup analyses.
paign, streamed soap opera videos, avatar-guided 
computer programs);
3. combined innovations (innovations that combined 
both mHealth (SMS/phone calls) with internet 
enabled mHealth/eHealth).
Only one subgroup reported similar outcomes 
which could be pooled, SMS and phone calls, for 
the following outcomes: (1) clinic attendance with 
SMS and (2) ART adherence via Medication Event 
Monitoring System (MEMS) caps, with SMS. We 
pooled these outcomes using a random effects 
subgroup analysis. Given the diversity in the sample 
populations between studies, we used the random 
effect meta-analysis model with the DerSimonian and 
Laird estimator (moments method) of the between-
study variance to calculate the pooled effect. We 
generated forest plots for visual representation 
of heterogeneity and pooled OR with 95% CI. We 
 5Daher J, et al. BMJ Open 2017;7:e017604. doi:10.1136/bmjopen-2017-017604
Open Access
performed all statistical analyses using Stata/IC, V.13 
(Stata).31
narrative analysis
We narratively described all other data using as follows:
Digital innovations were classified into the following 
groups based on the strength of evidence: high/strong 
evidence (metrics at 75%–100%), moderate evidence 
(51%–74%) and low/weak evidence (50% or less).
Acceptability
Acceptability was defined as the receptivity in using digital 
innovations.
Feasibility
Feasibility was defined as the perceived convenience in 
using digital innovations. It was reported with various 
metrics: completion, retention, response and referral 
rates.
Impact
Impact was defined as a statistically significant improve-
ment in measured outcomes compared with a compar-
ator group (ie, control group or baseline observations). 
The metrics used to evaluate impact were (1) atten-
dance rate, (2) ART adherence, (3) risk reduction, (4) 
self-care and (5) partner notification. Impact measures 
were evaluated on two criteria: effect size and precision. 
Effect size was assessed when data on a comparator group 
were made available. Precision of the effect estimate was 
assessed whenever reported, as it reflects the variance or 
spread of results.
Quality assessment
We assessed study quality for both clinical trials and obser-
vational studies. We used the Cochrane Risk of Bias Tool 
for trials, and the Newcastle-Ottawa quality assessment 
scale for observational studies.
results
Of 4252 citations identified through our extensive search, 
792 were selected for full-text screening, and 99 citations 
met our inclusion criteria and were included in this 
review for evidence synthesis (refer figure 1).
study characteristics
By geographical location, 37% (37/99) of studies were 
conducted in North America, 26% (26/99) in Sub-Sa-
haran Africa, 24% (24/99) in Europe, 7% (7/99) in 
Oceania, 3% (3/99) in South-East Asia and 2% (2/99) in 
South America.
By study design, the majority were trials: 38% (38/99) 
were RCTs, 16% (16/99) uncontrolled trials and 1% 
(1/99) non-randomised controlled trials. Others included 
quasi-experimental studies, of which many used histor-
ical controls (24%, 24/99) and observational studies (ie, 
cross-sectional and feasibility studies) (20%, 20/99).
HIV was the most frequently reported infection (74%, 
73/99 studies), followed by chlamydia/gonorrhoea (CT/
GC) (10%, 10/99). Combinations of HIV with STIs (eg, 
syphilis) (8%, 8/99), human papillomavirus (HPV) (4%, 
4/99) and hepatitis A/B/C (HBV) (4%, 4/99) were also 
reported.
In terms of study populations, PLHIV were prominent 
across studies (42%, 42/99) followed by other high-risk 
groups (ie, MSM/bisexual men, drug users, pregnant 
women/mother–infant pairs, African-Americans, sex 
workers and visible minorities) (28%, 28/99), general 
clinic attendees (16%, 16/99), CT/HBV-infected indi-
viduals (4%, 4/99) and residents of a specific area (9%, 
9/99).
Innovations
Digital innovations were documented across the spectrum.
mHealth innovations (SMS/phone calls only) were 
evaluated in 70% (69/99) of studies.20 32–99Seventy-two 
per cent (50/69) were SMS-based and 28% (19/69) used 
phone calls or a combination of both (refer to figure 2 
and see online supplementary appendix file 3).
Internet-enabled mHealth and other internet-based 
eHealth innovations were evaluated in 21% (21/99) 
of studies.100–120 These innovations consisted of many 
different forms: social media and online campaigns 
(9/21), avatar-guided computer programs (2/21), mobile 
applications (5/21), combination of social media and 
websites (2/21), websites (1/21), telemedicine services 
(1/21) and streamed soap opera videos (1/21) (refer to 
figure 2 and see online supplementary appendix file 3).
Combined innovations were evaluated in 9% (9/99) 
of studies.121–129 Innovations consisted of SMS+web-
sites/ interactive websites (4/9), SMS+mobile applica-
tion (3/9) and SMS+social media (including online 
campaigns) (2/9) (refer to figure 2 and see online Supple-
mentary appendix file 3).
Measures and metrics
A vast majority (84%, 83/99) of studies focused on 
impact measure and metrics, while about 12% (12/99) 
focused only on feasibility and the remaining 4% (4/99) 
on acceptability. Within impact measures, metrics such 
as clinic attendance rates were reported in 45% (37/83) 
of studies, followed by ART adherence at 35% (29/83), 
HIV/STIs risk reduction behaviours at 13% (11/83), 
turnaround time from testing to treatment at 2% (2/83), 
partner notification at 2% (2/83) and self-care at 2% 
(2/83).
Analyses
Subgroup pooled analyses
It was possible to perform subgroup analyses on outcomes 
that were consistently documented: clinic attendance in 
14 quasi-experimental studies that used SMS reminders 
and MEMS-based ART adherence in four randomised 
controlled trials (RCTs) evaluating SMS. The pooled 
estimate for the impact of SMS reminders on attendance 
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rates was 1.76 (95% CI: 1.28 to 2.42) (refer to figure 3A). 
The pooled estimate for the impact of SMS on ART adher-
ence tracked via MEMS caps was also significant, OR=2.15 
(95% CI: 1.18 to 3.91) (refer to figure 3B).32 47 48
narrative analysis
Impact
Non-internet-based mHealth (SMS/PC only)
Of 69 studies, positive results were reported for the 
following outcomes: clinic attendance (63%, 19/30 
studies, of which 84% reached statistical significance), 
ART adherence (63%, 15/24 studies, of which 93% 
reached statistical significance), turnaround time from 
testing to treatment (67%, 2/3 studies). However, SMS 
reported a limited effect on risk reduction behaviours 
(3/7, 43%).
Internet-based mHealth/eHealth
Studies evaluating internet-based eHealth innovations 
(21/99) reported results that were largely in favour of the 
following innovations: social media-based interventions 
for clinic attendance; avatar-guided and mobile applica-
tions for ART adherence; social media, avatar and soap 
opera videos for risk reduction behaviours; mobile app 
for self-care.
Social media contributed to higher testing uptake 
rates in all studies (6/6, 100%). A social media-based 
campaign increased HIV testing by 252% (n=1500; 19% 
from baseline 5.4%, p<0.01) and Syphilis testing by 248% 
(18.8% from baseline 5·4%, p<0.01), while another 
campaign increased HIV testing by 52% compared 
with control (n=625; 63.7% vs 42% in controls, OR=2.9 
(95% CI: 1.8 to 4.7)).100 115 Four campaigns guaranteed 
rapid in-home HIV testing for all those who requested it 
online.100 101 108 111 116
Avatar-guided programs and mobile applications 
improved ART adherence in all studies (4/4). Statis-
tically significant outcomes were reported in 2/4 
programs (50%). These were (1) a personalised avatar-
guided computer program improved adherence (n=240; 
p=0.046); (2) a mobile application with immunosup-
pression graphs and medication reminders lowered viral 
load (n=28; p=0.023) and improved adherence (p=0.03) 
as well.102 104 In the other two studies, an avatar-guided 
program improved viral suppression and a mobile appli-
cation allowed for 100% adherence, but these were 
underpowered to detect a significant effect (n=76 and 
n=28, respectively).107 110
Social media, avatar and soap opera videos were 
successful at reducing risky sexual behaviour in all the 
reported studies (5/5). However, significant results 
were reported in only three of five studies: (1) social 
media-based interventions decreased unprotected sex 
acts by 65% (n=31; 3.11 vs baseline 8.96, p=0.042); (2) 
soap opera videos on HIV prevention reduced condom-
less sex by 78% (n=117; 78% reduction from baseline, 
p<0.001)103 106; (3) an avatar-guided computer program 
also lowered the odds of HIV transmission (n=240; 
OR=0.46, p=0.012).102 103 106 Even in two underpowered 
studies, social media-based interventions led to 40% and 
67% higher condom uptake (n=70 and n=50, respec-
tively).105 117
A mobile application increased self-care in the sole 
study in this category (1/1). A significantly higher self-
care performance among chronic HBV-infected indi-
viduals was reported compared with controls (n=53; 
p=0.001).112
Combined innovations
Studies evaluating combined innovations (9/99) showed 
success of social media+SMS in increasing clinic atten-
dance and partner notification; interactive websites+SMS 
in improving ART adherence; and mobile app+SMS in 
increasing self-care. Among the five impact studies, 80% 
reported a favourable outcome. An online campaign 
with SMS services increased CT, GC and HIV tests uptake 
by 41%, 91% and 190%, respectively123; an interactive 
website with SMS reminders improved ART adherence 
in drug users (n=20; p=0.02)121; a social media-based 
partner notification with SMS increased notified contacts 
by 144% (63.5% in 2011 from baseline 26% in 2010)126; 
and a mobile app with SMS significantly improved self-
care performance in HIV-infected individuals compared 
with baseline (n=19; p=0.002).129
Acceptability and feasibility
Overall, across studies that assessed acceptability/feasi-
bility, digital innovations were found to be highly accept-
able and feasible (75%–100%)%) in 26/31 and 20/31 
studies, respectively. mHealth innovations (SMS/PC 
only) were highly acceptable and feasible in 81% (13/16) 
and 75% (12/16) of studies, respectively.
Internet-based mHealth/eHealth innovations were 
highly acceptable and feasible in 92% (11/12) and 45% 
(5/11) of studies, respectively. All included innovations 
(ie, avatar, mobile app, social media and streamed videos) 
were highly acceptable.102–104 106 107 While avatar-guided 
program was rated high on feasibility, social media-based 
strategies were found to be less feasible101–103
Combined innovations were highly acceptable and 
feasible in 67% (2/3) and 75% (3/4) of studies, respec-
tively.121 124 The innovations that were rated high involved 
a combination of SMS and interactive websites.
Quality
Studies were individually evaluated on quality criteria, 
and biases were noted. Across trials, losses to follow-up 
were reported in 31% of RCTs and 55% of quasi-trials. 
Additionally, biases (ie, misclassification, recall bias) were 
of concern in 58% of the RCTs and 64% of quasi-ran-
domised trials (refer to online supplementary appendix 
file 4 and 5).
In observational studies, confounding (68%) and selec-
tion bias (66%) were observed (refer to  online supple-
mentary appendix file 6). Studies with small sample sizes, 
low power or insufficient follow-up time (eg, 3 weeks 
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or less) sometimes provided contradictory results when 
objective and subjective metrics evaluated the same 
outcome.
DIscussIOn
summary of findings
Overall, digital innovations reported positive effects on 
key metrics. We noted a strong positive effect of digital 
innovations on clinic attendance rates (70%; 26/37), 
ART adherence (69%; 20/29), risk reduction behaviours 
(67%; 8/12) and self-care (100%; 2/2). SMS/phone calls 
were not able to reduce risky sexual behaviours; however, 
social media-based interventions, particularly interac-
tive social media, were effective in reducing risky sexual 
behaviours. Acceptability was found to be high for all 
innovations. Feasibility estimates also remained high for 
all innovations, except for social media-based interven-
tions, possibly due to a perceived lack of privacy and confi-
dentiality. Combined innovations may thus offer promise 
in plugging this feasibility gap, with internet-based inno-
vations compensating for limitations in SMS-only strate-
gies and vice versa.
While mHealth (SMS/phone calls only) innovations 
were highly effective in improving clinic attendance, ART 
adherence and turnaround time from testing to treat-
ment, they did not report on other outcomes. It should 
be noted that SMS and phone calls alone failed to reduce 
risky sexual behaviours, which was not surprising as it is 
challenging to reduce risky behaviours with a prescriptive 
SMS alone. Population engagement is essential for risk 
reduction through qualitative research.
While internet-based mHealth/eHealth innovations 
(social media, avatar-guided computer programs, mobile 
apps and soap opera videos) demonstrated positive 
evidence on impact metrics, not all studies reached statis-
tical significance. Those that failed to report a statisti-
cally significant improvement in ART adherence had 
small sample sizes and were underpowered to detect 
these outcomes (n=76 vs n=240), and had less frequent 
sessions over a shorter evaluation period (2 sessions 
over 6 months vs 4 sessions over 9 months).102 107 For 
mobile applications, studies which reported significant 
effects recruited participants with varying level of adher-
ence,104 110 compared with studies which had high adher-
ence at baseline (≥95%) and did not show significance 
(due to smaller changes in effect). For social media-based 
campaigns, the two studies that did not reach statistical 
significance in reducing risky sexual behaviours lacked an 
interactive component and simply displayed educational 
material, while the study that showed significant effect 
engaged the participants by allowing them to contact 
professional cognitive behavioural therapists via live chat 
sessions.103 105 117
In terms of quality, confounding and selection bias 
were noted in observational and quasi-experimental 
studies, and loss to follow-up in some trials. Nevertheless, 
the overall validity of the findings from this review was not 
threatened by biases, as a large proportion of our data 
were derived from trials. While clinical trials were gener-
ally high quality, observational studies were medium to 
low quality.
Consistent reporting of metrics was lacking, which 
prevented a comprehensive meta-analysis. Objectives, 
end points, metrics and measures are equally important 
in feasibility studies and must be well designed to generate 
high-quality evidence.
Our review is an exhaustive assessment of the role of 
digital innovations in improving prevention and care 
for HIV/STIs. Our findings resonate with many smaller 
systematic reviews, which have separately evaluated 
individual components of digital innovation, such as 
SMS-based mHealth.22 23 130–137 Other systematic reviews 
evaluating social media-based interventions reported 
similar findings to ours, in improved testing uptake or 
improvements in sexual health.25–27 138 139
Our review makes a valuable addition to the growing 
body of evidence by highlighting the success of other 
interactive and engaging innovations such as avatar-
guided computer programs, mobile apps, streamed soap 
opera videos and combined innovations. These inte-
grated innovations and programs are gaining in popu-
larity because of their power to engage rural and urban 
audiences at many levels.
Designing combined innovations that are complemen-
tarity of various media, methods, platforms and messaging 
may deliver best results. This complementarity may also 
encourage participant engagement to improve preven-
tion and care metrics and measures sustainably over time. 
Engagement is challenging when only one innovation 
(eg, mHealth SMS/phone calls only) is the sole focus, 
where boredom is likely.
caveats and implications for future research
There are some caveats to considering design and evalua-
tion of innovations. Future research needs to be focused 
on tailoring innovations to the context and population, 
and program objectives. Innovations aiming to reduce 
risky sexual behaviours could be interactive and tailored 
to the setting and population, with a deep understanding 
of patients’ needs and preferences.137 140 141 Any commu-
nication with patients could be customised for timing 
to avoid fatigue with its uptake. For example, patients 
may be more responsive to weekly versus daily SMS ART 
reminders.32 142
Study quality is essential to generating meaningful 
results. Large and representative samples of the under-
lying population and sound statistical techniques during 
data analysis or sampling methodology can minimise 
selection bias. Exploring reasons for differential losses 
to follow-up could inform future studies. Wherever 
possible, a control group should be included to differ-
entiate the Hawthorne effect from the effect of the 
intervention.143 Trials and impact designs can prevent 
or reduce confounding. Following checklists, like the 
one by the WHO mHealth Technical Evidence Review 
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Group on mHealth innovations, is suggested and 
encouraged.144
Objective measures (eg, HIV/STIs diagnosis, viral 
load) are desired in reporting of quantitative outcomes, 
over subjective self-reported data (eg, condom use, 
self-reported adherence). This could potentially reduce 
some biases (misclassification biases or desirability/recall 
biases) that are observed with subjective reporting.
Qualitative data are rich and complement the under-
standing of all the contextual and population needs, and 
capture the dynamics of sustainability and change. They 
need to be integrated with quantitative data to provide a 
holistic picture of uptake of any digital innovation.
Quality of digital data will merit from an improvement. 
Across studies, a lack of integrated online impact metrics 
in evaluating the success of innovations was evident. With 
continuously evolving digital media, inventing new ways 
to evaluate acceptability and feasibility becomes neces-
sary. For example, some studies tracked online metrics 
via Google analytics.74 100 101 121–124 Synergy with industry 
powered metrics could be a new wave to measure success 
of digital innovations.
To scale up proven innovations, a multistakeholder 
engagement is necessary. For that, data and metrics that 
appeal to all sections of stakeholders will be needed. 
In addition to improving the quality of randomised 
controlled trials and quasi-experimental impact studies, 
qualitative studies, cost-effectiveness studies and usability 
studies are also needed.
Implications for policy and practice
In consonance with other systematic reviews, evidence 
at scale and over time was scarce.138 This limits the projec-
tion of the long-term sustainability and cost-effective-
ness of digital innovations. More evidence on scale-up, 
cost-savings and cost-effectiveness from Sub-Saharan 
Africa and Asia is needed. Future investments that incen-
tivise both the development and evaluation of combined 
innovations by government and industry alike, and focus 
on sustainability of digital innovations with public and 
private partnerships, are urgently needed.
cOnclusIOn
To control HIV/STIs globally, we need novel and 
disruptive innovations that will uniquely impact health 
outcomes across the spectrum of access, engagement, 
treatment and retention so as to impact health service 
delivery. On one hand, mHealth (SMS/phone calls only) 
and internet-based mHealth/eHealth were found accept-
able, feasible and offered complementarity in improving 
prevention and care of HIV/STIs. On the other hand, 
when combined, they provided customised and contextu-
alised solutions for hard-to-reach populations.
Innovations need to be proven for impact and cost-effec-
tiveness, using a combination of clinical trials, quasi-ran-
domised studies, observational studies and qualitative 
research studies. Integrating these innovations across 
various levels of healthcare with clear evaluation, moni-
toring and documentation of metrics will facilitate their 
integration within existing health service delivery models 
so as to efficiently impact health outcomes over time.
Findings from this comprehensive review will be infor-
mative to all stakeholders—innovators, researchers, 
healthcare practitioners, policy makers and funders—
worldwide seeking evidence on integrating and funding 
innovations, to make (impact) the entire spectrum of 
HIV/STI care.
Acknowledgements The authors would like to acknowledge Ms. Megan 
Smallwood for her assistance in editing the manuscript. 
contributors NPP, JD: concept, design. NPP: data critiquing, write-up, critique, and 
overall responsibility of the data. JD: data synthesis, write-up, critiquing. RV, BL and 
SD: data synthesis, write"up and critique. JK, TP and KD: write"up and critique.
Funding Grand Challenges Canada Transition to Scale; Grant number 0710"05.
FRSQ Salary Award Chercheur"Boursier Junior 2. 
competing interests None declared.
Provenance and peer review Not commissioned; externally peer reviewed.
Data sharing statement No additional data are available. This is a systematic 
review/syntheses of existing studies, therefore all data are reported in the tables. 
Open Access This is an Open Access article distributed in accordance with the 
terms of the Creative Commons Attribution (CC BY 4.0) license, which permits 
others to distribute, remix, adapt and build upon this work, for commercial use, 
provided the original work is properly cited. See: http:// creativecommons. org/ 
licenses/ by/ 4. 0/
© Article author(s) (or their employer(s) unless otherwise stated in the text of the 
article) 2017. All rights reserved. No commercial use is permitted unless otherwise 
expressly granted.
reFerences
 1. The World Health Organization. Sexually transmitted infections 
(STIs): fact sheet N°110: WHO media centre, 2015. Updated Dec 
2015. http://www. who. int/ mediacentre/ factsheets/ fs110/ en/. 
(accessed 27 Jan 2016).
 2. The World Health Organization. Hepatitis B: fact sheet N°204: WHO 
media centre. 2015 http://www. who. int/ mediacentre/ factsheets/ 
fs204/ en/ (accessed 27 Jan 2016).
 3. The World health Organization. Hepatitis C: fact sheet N°164, 2015. 
http://www. who. int/ mediacentre/ factsheets/ fs164/ en/ (accessed 27 
Jan 2016).
 4. The Joint United Nations Programme on HIV/AIDS. Fact Sheet 
2015, 2015. h ttp://www. unaids.org /en/ reso urce s/ca mpaigns/ 
HowAIDSchange deveryt hing / factsheet (accessed 17 Dec 2016).
 5. Newman L, Rowley J, Vander Hoorn S, et al. Global estimates of 
the prevalence and incidence of four curable sexually transmitted 
infections in 2012 based on systematic review and global reporting. 
PLoS One 2015;10:e0143304.
 6. The Joint United Nations Programme on HIV/AIDS. The gap report. 
Geneva: UNAIDS, 2014.
 7. Kagee A, Remien RH, Berkman A, et al. Structural barriers to ART 
adherence in Southern Africa: Challenges and potential ways 
forward. Glob Public Health 2011;6:83–97.
 8. Pai NP. Multiplexed point-of-care assays for HIV and co-infections 
for resource constrained settings: a perspective. Future Microbiol 
2015;10:1393–6.
 9. Pai NP, Vadnais C, Denkinger C, et al. Point-of-care testing for 
infectious diseases: diversity, complexity, and barriers in low- and 
middle-income countries. PLoS Med 2012;9:e1001306.
 10. Rosen S, Fox MP. Retention in HIV care between testing and 
treatment in sub-Saharan Africa: a systematic review. PLoS Med 
2011;8:e1001056.
 11. Ryu S. Book review: mHealth: new horizons for health through 
mobile technologies: based on the findings of the second global 
survey on eHealth (global observatory for eHealth series, volume 3). 
Healthc Inform Res 2012;18:231–3.
 12. Free C, Phillips G, Watson L, et al. The effectiveness of mobile-
health technologies to improve health care service delivery 
 9Daher J, et al. BMJ Open 2017;7:e017604. doi:10.1136/bmjopen-2017-017604
Open Access
processes: a systematic review and meta-analysis. PLoS Med 
2013;10:e1001363.
 13. The World Bank. Maximizing mobile: information and 
communication technologies for development. Washington DC: 
International Bank for Reconstruction and Development The World 
Bank, 2012.
 14. eMarketer. Smartphone user penetration as percentage of total 
global population from 2011 to 2018: Statistica- The Statistics 
Portal, 2014. http://www. statista. com/ statistics/ 203734/ global- 
smartphone- penetration- per- capita- since- 2005/ (accessed 19 Feb 
2016).
 15. eMarketer. Mobile phone internet user penetration worldwide 
from 2014 to 2019: Statistica- The Statistics Potal, 2014. http://
www. statista. com/ statistics/ 284202/ mobile- phone- internet- user- 
penetration- worldwide/ (accessed 19 Feb 2016).
 16. Oulasvirta A, Rattenbury T, Ma L, et al. Habits make smartphone 
use more pervasive. Pers Ubiquitous Comput 2012;16:105–14.
 17. Topol EJ. The creative destruction of medicine: how the digital 
revolution will create better health care. New York: Basic Books, 
2012.
 18. Akter S, Ray P. mHealth - an ultimate platform to serve the 
unserved. Yearb Med Inform 2010:94–100 (Epub ahead of print 13 
Oct 2010).
 19. Ali EE, Chew L, Yap KY-L. Evolution and current status of mhealth 
research: a systematic review. BMJ Innov 2016;2:33–40.
 20. Lester RT, Ritvo P, Mills EJ, et al. Effects of a mobile phone short 
message service on antiretroviral treatment adherence in Kenya 
(WelTel Kenya1): a randomised trial. Lancet 2010;376:1838–45.
 21. Ambia J, Mandala J. A systematic review of interventions to 
improve prevention of mother-to-child HIV transmission service 
delivery and promote retention. J Int AIDS Soc 2016;19:20309.
 22. Conserve DF, Jennings L, Aguiar C, et al. Systematic review of 
mobile health behavioural interventions to improve uptake of HIV 
testing for vulnerable and key populations. J Telemed Telecare 
2017;23:347–59.
 23. L'Engle KL, Mangone ER, Parcesepe AM, et al. Mobile phone 
interventions for adolescent sexual and reproductive health: a 
systematic review. Pediatrics 2016;138:e20160884.
 24. Lima IC, Galvão MT, Alexandre HO, et al. Information and 
communication technologies for adherence to antiretroviral 
treatment in adults with HIV/AIDS. Int J Med Inform 
2016;92:54–61.
 25. Dunne A, McIntosh J, Mallory D. Adolescents, sexually Transmitted 
infections, and education using social media: a review of the 
literature. J Nurse Pract 2014;10:409–16.
 26. Jones K, Eathington P, Baldwin K, et al. The impact of health 
education transmitted via social media or text messaging on 
adolescent and young adult risky sexual behavior: a systematic 
review of the literature. Sex Transm Dis 2014;41:413–9.
 27. Schnall R, Travers J, Rojas M, et al. eHealth interventions for HIV 
prevention in high-risk men who have sex with men: a systematic 
review. J Med Internet Res 2014;16:228–37.
 28. Moher D, Liberati A, Tetzlaff J, et al. Preferred reporting items for 
systematic reviews and meta-analyses: the PRISMA statement. Ann 
Intern Med 2009;151:264–9.
 29. Chiavegatti T, Vijh R, Pant Pai N. Metrics beyond accuracy for HIV 
point-of-care tests: a systematic review of evidence. Can J Infect 
Dis Med Microbiol 2014;25(Suppl A):90.
 30. Pai M, Filion K. Classification of study designs (Version 8) Montreal. 
McGill University, 2014. http://www. teachepi. org/ documents/ 
courses/ Classification% 20Design. pdf.
 31. Harris R, Bradburn M, Deeks J, et al. Metan: fixed- and random-
effects meta-analysis. Stata Journal 2008;8:3–28.
 32. Pop-Eleches C, Thirumurthy H, Habyarimana JP, et al. Mobile 
phone technologies improve adherence to antiretroviral treatment 
in a resource-limited setting: a randomized controlled trial of text 
message reminders. AIDS 2011;25:825–34.
 33. Dowshen N, Kuhns LM, Johnson A, et al. Improving adherence to 
antiretroviral therapy for youth living with HIV/AIDS: a pilot study 
using personalized, interactive, daily text message reminders. J 
Med Internet Res 2012;14:e51.
 34. Menon-Johansson AS, McNaught F, Mandalia S, et al. Texting 
decreases the time to treatment for genital Chlamydia trachomatis 
infection. Sex Transm Infect 2006;82:49–51.
 35. Finocchario-Kessler S, Gautney BJ, Khamadi S, et al. If you text 
them, they will come: using the HIV infant tracking system to 
improve early infant diagnosis quality and retention in Kenya. AIDS 
2014;28(Suppl 3):S313–21.
 36. Lim EJ, Haar J, Morgan J. Can text messaging results reduce 
time to treatment of Chlamydia trachomatis? Sex Transm Infect 
2008;84:563–4.
 37. Bailey S, Scalley B, Gilles M. Text 2 treat - using SMS to recall 
clients for treatment. Int J STD AIDS 2014;25:1038–40.
 38. Smillie K, Van Borek N, Abaki J, et al. A qualitative study 
investigating the use of a mobile phone short message service 
designed to improve HIV adherence and retention in care in Canada 
(WelTel BC1). J Assoc Nurses AIDS Care 2014;25:614–25.
 39. Reback CJ, Fletcher JB, Shoptaw S, et al. Exposure to theory-
driven text messages is associated with HIV risk reduction among 
methamphetamine-using men who have sex with men. AIDS Behav 
2015;19(Suppl 2):130–41.
 40. Evans C, Turner K, Blake H, et al. Text messaging to encourage 
uptake of HIV testing amongst African communities: findings from 
a theory based feasibility study. HIV Medicine 2015;16(Suppl 
2):54.
 41. Dowshen N, Kuhns LM, Gray C, et al. Feasibility of interactive 
text message response (ITR) as a novel, real-time measure of 
adherence to antiretroviral therapy for HIV+ youth. AIDS Behav 
2013;17:2237–43.
 42. Cornelius JB, Dmochowski J, Boyer C, et al. Text-messaging-
enhanced HIV intervention for African American adolescents: a 
feasibility study. J Assoc Nurses AIDS Care 2013;24:256–67.
 43. Ammassari A, Trotta MP, Mussini C, et al. Mobile phone intervention 
based on short message system (SMS) improve adherence 
behavior in HIV-infected non-adherent to antiretroviral therapy. The 
HI-Vision Study. Infection 2010;38(Suppl 52):52.
 44. Ammassari A, Trotta MP, Shalev N, et al. Timed short messaging 
service improves adherence and virological outcomes in HIV-
1-infected patients with suboptimal adherence to antiretroviral 
therapy. J Acquir Immune Defic Syndr 2011;58:e113–e115.
 45. Segaren N, Lewis T, Desinor O, et al. The distribution and use of cell phones 
to mothers of HIV-positive infants identified by the Haiti National Early Infant Diagnosis of 
HIV program (EID): a model for increasing adherence? XIX International AIDS Conference  
Washington DC, 2012.
 46. Sheppard Z, Walsh J, Weston R. The TRxCare™ adherence support 
system: a pilot study of its acceptability to patients on virologically 
successful HAART. Birmingham: 18th Annual Conference of British 
HIV Association, 2012.
 47. da Costa TM, Barbosa BJ, Gomes e Costa DA, et al. Results of a 
randomized controlled trial to assess the effects of a mobile SMS-
based intervention on treatment adherence in HIV/AIDS-infected 
Brazilian women and impressions and satisfaction with respect to 
incoming messages. Int J Med Inform 2012;81:257–69.
 48. Sabin LL, Bachman DeSilva M, Gill CJ, et al. Improving adherence 
to antiretroviral therapy with triggered real-time text message 
reminders: the China adherence through technology study. J Acquir 
Immune Defic Syndr 2015;69:551–9.
 49. Brook G, Farmer T, Murphy S, et al. Using SMS Text reminders 
to reduce ‘did not attend’ (DNA) rates in sexual health and HIV 
appointment clinics. Sex Transm Infect 2013;89(Suppl 1):A1–A428.
 50. Kliner M, Knight A, Mamvura C, et al. Using no-cost mobile phone 
reminders to improve attendance for HIV test results: a pilot study 
in rural Swaziland. Infect Dis Poverty 2013;2:12.
 51. Farmer T, Brook G, McSorley J, et al. Using short message service 
text reminders to reduce 'did not attend' rates in sexual health and 
HIV appointment clinics. Int J STD AIDS 2014;25:289–93.
 52. Brook G, Burton J, McSorley J, et al. The Effectiveness of SMS 
Texts For Reminding Patients at High Risk of STIs and HIV to 
Return For Testing. Sex Transm Infect 2013;89(Suppl 1):A1–A428.
 53. Guy R, Wand H, Knight V, et al. SMS reminders improve re-
screening in women and heterosexual men with chlamydia infection 
at Sydney Sexual Health Centre: a before-and-after study. Sex 
Transm Infect 2013;89:11–15.
 54. Burton J, Brook G, McSorley J, et al. The utility of short message 
service (SMS) texts to remind patients at higher risk of STIs and 
HIV to reattend for testing: a controlled before and after study. Sex 
Transm Infect 2014;90:11–3.
 55. Desai M, Burns F, Mercey D, et al. Active recall of men who have 
sex with men (MSM) for an HIV/STI testing: a feasible and effective 
strategy? HIV Medicine 2014;15(Suppl 3):17–159.
 56. Kharbanda EO, Stockwell MS, Fox HW, et al. Text message 
reminders to promote human papillomavirus vaccination. Vaccine 
2011;29:2537–41.
 57. Vilella A, Bayas JM, Diaz MT, et al. The role of mobile phones in 
improving vaccination rates in travelers. Prev Med 2004;38:503–9.
 58. Downing SG, Cashman C, McNamee H, et al. Increasing chlamydia 
test of re-infection rates using SMS reminders and incentives. Sex 
Transm Infect 2013;89:16–19.
 59. Odeny TA, Bailey RC, Bukusi EA, et al. Text messaging to 
improve attendance at post-operative clinic visits after adult male 
circumcision for HIV prevention: a randomized controlled trial. PLoS 
One 2012;7:e43832.
10 Daher J, et al. BMJ Open 2017;7:e017604. doi:10.1136/bmjopen-2017-017604
Open Access 
 60. de Tolly K, Skinner D, Nembaware V, et al. Investigation into 
the use of short message services to expand uptake of human 
immunodeficiency virus testing, and whether content and dosage 
have impact. Telemed J E Health 2012;18:18–23.
 61. Bigna JJ, Noubiap JJ, Kouanfack C, et al. Effect of mobile phone 
reminders on follow-up medical care of children exposed to or 
infected with HIV in Cameroon (MORE CARE): a multicentre, 
single-blind, factorial, randomised controlled trial. Lancet Infect Dis 
2014;14:600–8.
 62. Rand CM, Brill H, Albertin C, et al. Effectiveness of centralized 
text message reminders on human papillomavirus immunization 
coverage for publicly insured adolescents. J Adolesc Health 
2015;56:S17–S20.
 63. Matheson EC, Derouin A, Gagliano M, et al. Increasing HPV 
vaccination series completion rates via text message reminders. J 
Pediatr Health Care 2014;28:e35–9.
 64. Schwartz SR, Clouse K, Yende N, et al. Acceptability and feasibility 
of a mobile phone-based case management intervention to retain 
mothers and infants from an option B+ program in postpartum HIV 
care. Matern Child Health J 2015;19:2029–37.
 65. Belzer ME, Naar-King S, Olson J, et al. The use of cell phone 
support for non-adherent HIV-infected youth and young adults: 
an initial randomized and controlled intervention trial. AIDS Behav 
2014;18:686–96.
 66. Maduka O, Tobin-West CI. Adherence counseling and reminder 
text messages improve uptake of antiretroviral therapy in a tertiary 
hospital in Nigeria. Niger J Clin Pract 2013;16:302–8.
 67. Kebaya L, Nduati R, Wamalwa D, et al. Efficacy of mobile phone 
use on adherence to nevirapine prophylaxis and retention In care 
among the Hiv-exposed infants In pmtct: a randomised controlled 
trial. Arch Dis Child 2014;99(Suppl 2):A1–620.
 68. Hardy H, Kumar V, Doros G, et al. Randomized controlled trial of a 
personalized cellular phone reminder system to enhance adherence 
to antiretroviral therapy. AIDS Patient Care STDS 2011;25:153–61.
 69. DiClemente RJ, Wingood GM, Sales JM, et al. Efficacy of a 
telephone-delivered sexually transmitted infection/human 
immunodeficiency virus prevention maintenance intervention 
for adolescents: a randomized clinical trial. JAMA Pediatr 
2014;168:938–46.
 70. Cornelius JB, Cato M, Lawrence JS, et al. Development and 
pretesting multimedia HIV-prevention text messages for mobile cell 
phone delivery. J Assoc Nurses AIDS Care 2011;22:407–13.
 71. Dean AL, Makin JD, Kydd AS, et al. A pilot study using interactive 
SMS support groups to prevent mother-to-child HIV transmission in 
South Africa. J Telemed Telecare 2012;18:399–403.
 72. Juzang I, Fortune T, Black S, et al. A pilot programme using mobile 
phones for HIV prevention. J Telemed Telecare 2011;17:150–3.
 73. Kalichman SC, Kalichman MO, Cherry C, et al. Brief behavioral 
self-regulation counseling for HIV treatment adherence delivered by 
cell phone: an initial test of concept trial. AIDS Patient Care STDS 
2011;25:303–10.
 74. Mbuagbaw L, Thabane L, Ongolo-Zogo P, et al. The Cameroon 
Mobile Phone SMS (CAMPS) trial: a randomized trial of text 
messaging versus usual care for adherence to antiretroviral therapy. 
PLoS One 2012;7:e46909.
 75. Moore DJ, Poquette A, Casaletto KB, et al. Individualized texting 
for adherence building (iTAB): improving antiretroviral dose timing 
among HIV-infected persons with co-occurring bipolar disorder. 
AIDS Behav 2015;19:459–71.
 76. Norton BL, Person AK, Castillo C, et al. Barriers to using text 
message appointment reminders in an HIV clinic. Telemed J E 
Health 2014;20:86–9.
 77. Odeny TA, Bailey RC, Bukusi EA, et al. Effect of text messaging to 
deter early resumption of sexual activity after male circumcision 
for HIV prevention: a randomized controlled trial. J Acquir Immune 
Defic Syndr 2014;65:e50–7.
 78. Bauermeister J, Giguere R, Leu CS, et al. Interactive voice response 
system: data considerations and lessons learned during a rectal 
microbicide placebo adherence trial for young men who have sex 
with men. J Med Internet Res 2017;19:S57–8.
 79. Belzer ME, Kolmodin MacDonell K, Clark LF, et al. Acceptability and 
Feasibility of a Cell Phone Support Intervention for Youth Living with 
HIV with Nonadherence to Antiretroviral Therapy. AIDS Patient Care 
STDS 2015;29:338–45.
 80. Shet A, De Costa A, Kumarasamy N, et al. Effect of mobile 
telephone reminders on treatment outcome in HIV: evidence from a 
randomised controlled trial in India. BMJ 2014;349:g5978.
 81. Reid MJ, Dhar SI, Cary M, et al. Opinions and attitudes of 
participants in a randomized controlled trial examining the efficacy 
of SMS reminders to enhance antiretroviral adherence: a cross-
sectional survey. J Acquir Immune Defic Syndr 2014;65:e86–8.
 82. Roth AM, Hensel DJ, Fortenberry JD, et al. Feasibility and 
acceptability of cell phone diaries to measure HIV risk behavior 
among female sex workers. AIDS Behav 2014;18:2314–24.
 83. Barnabas RV, van Rooyen H, Tumwesigye E, et al. Uptake of 
antiretroviral therapy and male circumcision after community-based 
HIV testing and strategies for linkage to care versus standard clinic 
referral: a multisite, open-label, randomised controlled trial in South 
Africa and Uganda. Lancet HIV 2016;3:e212–20.
 84. Bassett IV, Coleman SM, Giddy J, et al. Sizanani: a randomized trial 
of health system navigators to improve linkage to HIV and TB care 
in South Africa. J Acquir Immune Defic Syndr 2016;73:154–60.
 85. Cantudo-Cuenca MR, Manzano-Garcia M, Jimenez-Galan R, 
et al. Effect of mobile phone short messages on antiretroviral 
treatment adherence among HIV infected patients. Int J Clin Pharm 
2016;38:517.
 86. Haberer JE, Musiimenta A, Atukunda EC, et al. Short message 
service (SMS) reminders and real-time adherence monitoring 
improve antiretroviral therapy adherence in rural Uganda. AIDS 
2016;30:1295–300.
 87. Jeffries C, Ross P, Matoff-Stepp S, et al. Ucare4life: mobile texting 
to improve HIV care continuum outcomes for minority youth. Topics 
in Antiviral Medicine 2016;24:427.
 88. Joseph Davey D, Nhavoto JA, Augusto O, et al. SMSaúde: 
Evaluating Mobile Phone Text Reminders to Improve Retention in 
HIV Care for Patients on Antiretroviral Therapy in Mozambique. J 
Acquir Immune Defic Syndr 2016;73:e23–30.
 89. Kampman C, Koedijk F, Driessen-Hulshof H, et al. Retesting young 
STI clinic visitors with urogenital Chlamydia trachomatis infection 
in the Netherlands; response to a text message reminder and 
reinfection rates: a prospective study with historical controls. Sex 
Transm Infect 2016;92:124–9.
 90. Kassaye SG, Ong'ech J, Sirengo M, et al. Cluster-randomized 
controlled study of SMS text messages for prevention of mother-
to-child transmission of HIV in rural kenya. AIDS Res Treat 
2016;2016:1289328–8.
 91. McIver R, Dyda A, McNulty AM, et al. Text message reminders do 
not improve hepatitis B vaccination rates in an Australian sexual 
health setting. J Am Med Inform Assoc 2016;23:e88–e92.
 92. Njuguna N, Ngure K, Mugo N, et al. The effect of human 
immunodeficiency Virus prevention and reproductive health text 
messages on human immunodeficiency virus testing among 
young women in rural Kenya: a pilot study. Sex Transm Dis 
2016;43:353–9.
 93. Nsagha DS, Lange I, Fon PN, et al. A randomized controlled trial 
on the usefulness of mobile text phone messages to improve the 
quality of care of HIV and AIDS patients in Cameroon. Open AIDS J 
2016;10:93–103.
 94. Nyatsanza F, McSorley J, Murphy S, et al. 'It's all in the message': 
the utility of personalised short message service (SMS) texts 
to remind patients at higher risk of STIs and HIV to reattend 
for testing-a repeat before and after study. Sex Transm Infect 
2016;92:393–5.
 95. Rana AI, van den Berg JJ, Lamy E, et al. Using a mobile health 
intervention to support HIV treatment adherence and retention 
among patients at risk for disengaging with care. AIDS Patient Care 
STDS 2016;30:178–84.
 96. Rand CM, Vincelli P, Goldstein NP, et al. Effects of Phone and Text 
Message Reminders on Completion of the Human Papillomavirus 
Vaccine Series. J Adolesc Health 2017;60:113–9.
 97. Coleman J, Bohlin KC, Thorson A, et al. Effectiveness of an SMS-
based maternal mHealth intervention to improve clinical outcomes 
of HIV-positive pregnant women. AIDS Care 2017;29:1–8.
 98. Garofalo R, Kuhns LM, Hotton A, et al. A randomized controlled 
trial of personalized text message reminders to promote medication 
adherence among HIV-positive adolescents and young adults. AIDS 
Behav 2016;20:1049–59.
 99. Georgette N, Siedner MJ, Zanoni B, et al. The acceptability and 
perceived usefulness of a weekly clinical SMS program to promote 
HIV antiretroviral medication adherence in KwaZulu-Natal, South 
Africa. AIDS Behav 2016;20:2629–38.
 100. Dowshen N, Lee S, Matty Lehman B, et al. IknowUshould2: 
feasibility of a youth-driven social media campaign to promote STI 
and HIV testing among adolescents in Philadelphia. AIDS Behav 
2015;19(Suppl 2):106–11.
 101. Jones M, Aderogba K, Drunis L. Providing rapid HIV testing in their 
homes for men who have sex with men, recruited via social media. 
HIV Medicine 2015;16(Suppl 2):50–1.
 102. Kurth AE, Spielberg F, Cleland CM, et al. Computerized counseling 
reduces HIV-1 viral load and sexual transmission risk: findings 
from a randomized controlled trial. J Acquir Immune Defic Syndr 
2014;65:611–20.
 11Daher J, et al. BMJ Open 2017;7:e017604. doi:10.1136/bmjopen-2017-017604
Open Access
 103. Lelutiu-Weinberger C, Pachankis JE, Gamarel KE, et al. Feasibility, 
acceptability, and preliminary efficacy of a live-chat social media 
intervention to reduce HIV risk among young men who have sex 
with men. AIDS Behav 2015;19:1214–27.
 104. Perera AI, Thomas MG, Moore JO, et al. Effect of a smartphone 
application incorporating personalized health-related imagery on 
adherence to antiretroviral therapy: a randomized clinical trial. AIDS 
Patient Care STDS 2014;28:579–86.
 105. Jones K, Baldwin KA, Lewis PR. The potential influence of a 
social media intervention on risky sexual behavior and Chlamydia 
incidence. J Community Health Nurs 2012;29:106–20.
 106. Jones R, Hoover DR, Lacroix LJ. A randomized controlled trial 
of soap opera videos streamed to smartphones to reduce risk of 
sexually transmitted human immunodeficiency virus (HIV) in young 
urban African American women. Nurs Outlook 2013;61:205–15.
 107. Naar-King S, Outlaw AY, Sarr M, et al. Motivational enhancement 
system for adherence (MESA): pilot randomized trial of a brief 
computer-delivered prevention intervention for youth initiating 
antiretroviral treatment. J Pediatr Psychol 2013;38:638–48.
 108. Elliot E, Rossi M, McCormack S, et al. Identifying undiagnosed 
HIV in men who have sex with men (MSM) by offering HIV home 
sampling via online gay social media: a service evaluation. Sex 
Transm Infect 2016;92:470–3.
 109. Garett R, Menacho L, Young SD. Ethical issues in using social 
media to deliver an HIV prevention intervention: results from the 
HOPE Peru Study. Prev Sci 2017;18:225–32.
 110. Himelhoch S, Kreyenbuhl J, Palmer-Bacon J, et al. Pilot feasibility 
study of Heart2HAART: a smartphone application to assist with 
adherence among substance users living with HIV. AIDS Care 
2017;29:898–904.
 111. Huang E, Marlin RW, Young SD, et al. Using grindr, a smartphone 
social-networking application, to increase HIV self-testing among 
black and latino men Wwho have sex with men in Los Angeles, 
2014. AIDS Educ Prev 2016;28:341–50.
 112. Jeon JH. Evaluation of a smartphone application for self-care 
performance of patients with chronic hepatitis B: a randomized 
controlled trial. Appl Nurs Res 2016;32:182–9.
 113. Polilli E, Sozio F, Di Stefano P, et al. Web-based HIV testing in 
Abruzzo, Italy: analysis of 15-Month activity Results. AIDS Patient 
Care STDS 2016;30:471–5.
 114. Przybyla SM, Eliseo-Arras RK, Krawiec G, et al. Feasibility and 
acceptability of a smartphone app for daily reports of substance 
use and antiretroviral therapy adherence among HIV-infected 
adults. AIDS Res Treat 2016;2016:1–12.
 115. Rhodes SD, McCoy TP, Tanner AE, et al. Using social media to 
increase HIV testing among gay and bisexual men, other men who 
have sex with men, and transgender persons: outcomes from a 
randomizedcommunity trial. Clin Infect Dis 2016;62:1450–3.
 116. Rosengren AL, Huang E, Daniels J, et al. Feasibility of using 
GrindrTM to distribute HIV self-test kits to men who have sex with 
men in Los Angeles, California. Sex Health 2016;13:389.
 117. Solorio R, Norton-Shelpuk P, Forehand M, et al. Tu Amigo Pepe: 
Evaluation of a Multi-media Marketing Campaign that Targets Young 
Latino Immigrant MSM with HIV Testing Messages. AIDS Behav 
2016;20:1973–88.
 118. Talal AH, Andrews P, McLeod A, et al. Telemedicine-based Hepatitis 
C Virus (HCV) management for individuals on opioid agonist 
treatment (OAT). Hepatology 2016;63(Suppl 1):475A.
 119. Henwood R, Patten G, Barnett W, et al. Acceptability and use 
of a virtual support group for HIV-positive youth in Khayelitsha, 
Cape Town using the MXit social networking platform. AIDS Care 
2016;28:898–903.
 120. Brayboy LM, Sepolen A, Mezoian T, et al. Girl Talk: a smartphone 
application to Tteach sexual health education to adolescent girls. J 
Pediatr Adolesc Gynecol 2017;30:23–8.
 121. Horvath KJ, Oakes JM, Rosser BR, et al. Feasibility, acceptability 
and preliminary efficacy of an online peer-to-peer social support 
ART adherence intervention. AIDS Behav 2013;17:2031–44.
 122. Götz HM, van Rooijen MS, Vriens P, et al. Initial evaluation of use of 
an online partner notification tool for STI, called 'suggest a test': a 
cross sectional pilot study. Sex Transm Infect 2014;90:195–200.
 123. Friedman AL, Brookmeyer KA, Kachur RE, et al. An assessment of 
the GYT: Get Yourself Tested campaign: an integrated approach 
to sexually transmitted disease prevention communication. Sex 
Transm Dis 2014;41:151–7.
 124. Hightow-Weidman LB, Muessig KE, Pike EC, et al.  
healthMpowerment. org: building community through a mobile-
optimized, online health promotion intervention. Health Educ Behav 
2015;42:493–9.
 125. Dokkum NF, Koekenbier RH, van den Broek IV, et al. Keeping 
participants on board: increasing uptake by automated respondent 
reminders in an Internet-based chlamydia screening in the 
Netherlands. MC Public Health 2012;12:176.
 126. Hightow-Weidman L, Beagle S, Pike E, et al. "No one’s at home 
and they won't pick up the phone": using the Internet and text 
messaging to enhance partner services in North Carolina. Sex 
Transm Dis 2014;41:143-8.
 127. Aronson ID, Cleland CM, Perlman DC, et al. Mobile screening to 
identify and follow-up with high risk, hiv negative youth. J Mob 
Technol Med 2016;5:9–18.
 128. Hirsch-Moverman Y, Daftary A, Yuengling KA, et al. Using mHealth 
for HIV/TB Treatment Support in Lesotho: Enhancing Patient-
Provider Communication in the START Study. J Acquir Immune 
Defic Syndr 2017;74(Suppl 1):S37–S43.
 129. John ME, Samson-Akpan PE, Etowa JB, et al. Enhancing self-care, 
adjustment and engagement through mobile phones in youth with 
HIV. Int Nurs Rev 2016;63:555–61.
 130. Guy R, Hocking J, Wand H, et al. How effective are short message 
service reminders at increasing clinic attendance? A meta-analysis 
and systematic review. Health Serv Res 2012;47:614–32.
 131. Free C, Phillips G, Galli L, et al. The effectiveness of mobile-health 
technology-based health behaviour change or disease management 
interventions for health care consumers: a systematic review. PLoS 
Med 2013;10:e1001362.
 132. Ershad Sarabi R, Sadoughi F, Jamshidi Orak R, et al. The 
Effectiveness of Mobile Phone Text Messaging in Improving 
Medication Adherence for Patients with Chronic Diseases: a 
Systematic Review. Iran Red Crescent Med J 2016;18:e25183.
 133. Finitsis DJ, Pellowski JA, Huedo-Medina TB, et al. Visual 
analogue scale (VAS) measurement of antiretroviral adherence 
in people living with HIV (PLWH): a meta-analysis. J Behav Med 
2016;39:1043–55.
 134. Kanters S, Park JJ, Chan K, et al. Interventions to improve 
adherence to antiretroviral therapy: a systematic review and 
network meta-analysis. Lancet HIV 2017;4:e31–e40.
 135. Mayer JE, Fontelo P. Meta-analysis on the effect of text message 
reminders for HIV-related compliance. AIDS Care 2017;29:1–9.
 136. Thakkar J, Kurup R, Laba TL, et al. Mobile telephone text 
messaging for medication adherence in chronic disease: A meta-
analysis. JAMA Intern Med 2016;176:340–9.
 137. Mbuagbaw L, Mursleen S, Lytvyn L, et al. Mobile phone text 
messaging interventions for HIV and other chronic diseases: 
an overview of systematic reviews and framework for evidence 
transfer. BMC Health Serv Res 2015;15:33.
 138. Muessig KE, Nekkanti M, Bauermeister J, et al. A systematic 
review of recent smartphone, Internet and Web 2.0 interventions 
to address the HIV continuum of care. Curr HIV/AIDS Rep 
2015;12:173–90.
 139. Gabarron E, Wynn R. Use of social media for sexual health 
promotion: a scoping review. Glob Health Action 2016;9:32193.
 140. Chávez NR, Shearer LS, Rosenthal SL. Use of digital media 
technology for primary prevention of STIs/HIV in youth. J Pediatr 
Adolesc Gynecol 2014;27:244–57.
 141. Barello S, Triberti S, Graffigna G, et al. eHealth for Patient 
Engagement: A Systematic Review. Front Psychol 2013;2015:6.
 142. Finitsis DJ, Pellowski JA, Johnson BT. Text message intervention 
designs to promote adherence to antiretroviral therapy (ART): 
a meta-analysis of randomized controlled trials. PLoS One 
2014;9:e88166.
 143. Fletcher WR, Fletcher WS. Chapter 8: Treatment. Clinical 
Epidemiology: The Essentials. 141. 4th ed. Baltimore: Lippincott 
Williams, 2005.
 144. Agarwal S, LeFevre AE, Lee J, et al. Guidelines for reporting of 
health interventions using mobile phones: mobile health (mHealth) 
evidence reporting and assessment (mERA) checklist. BMJ 
2016;352:i1174.
